ArticleWorld journal of gastroenterology2006

-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.

Carina Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.